| Seemab Gul Khan Md Pc | |
|
17876 Farmington Rd Bldg C Livonia MI 48152-3104 | |
| (734) 522-1406 | |
| (734) 522-1407 |
| Full Name | Seemab Gul Khan Md Pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 17876 Farmington Rd, Livonia, Michigan |
| Authorized Official Name and Position | Seemab Gul Khan (PRESIDENT) |
| Authorized Official Contact | 7345221406 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Seemab Gul Khan Md Pc 17876 Farmington Rd Bldg C Livonia MI 48152-3104 Ph: (734) 522-1406 | Seemab Gul Khan Md Pc 17876 Farmington Rd Bldg C Livonia MI 48152-3104 Ph: (734) 522-1406 |
| NPI Number | 1083893556 |
|---|---|
| Provider Enumeration Date | 10/31/2007 |
| Last Update Date | 11/01/2007 |
| Medicare PECOS PAC ID | 1153378740 |
|---|---|
| Medicare Enrollment ID | O20050929000577 |
News Archive
Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.
The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy. A form of blood cancer that arises from plasma cells, multiple myeloma usually grows in bone marrow, the soft, spongy tissue found inside most bones.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083893556 | NPI | - | NPPES |
| 4270819 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Seemab G Khan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1851485882 PECOS PAC ID: 4587611173 Enrollment ID: I20050406000083 |
News Archive
Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.
The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy. A form of blood cancer that arises from plasma cells, multiple myeloma usually grows in bone marrow, the soft, spongy tissue found inside most bones.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
› Verified 3 days ago
News Archive
Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.
The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy. A form of blood cancer that arises from plasma cells, multiple myeloma usually grows in bone marrow, the soft, spongy tissue found inside most bones.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
› Verified 3 days ago
Premier Urgent Care Of Livonia Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 18320 Farmington Rd, Livonia, MI 48152 Phone: 248-476-9200 | |
Spassova Medical Center Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 18770 Farmington Rd, Suite 100, Livonia, MI 48152 Phone: 734-284-6338 Fax: 734-293-0985 | |
Primary Care Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 20276 Middlebelt, Suite 7, Livonia, MI 48152 Phone: 248-477-8000 Fax: 248-477-8300 | |
Blessed Mc, Llc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 34441 8 Mile Rd, Ste 104, Livonia, MI 48152 Phone: 313-772-0406 | |
Ban Mechael, Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 19930 Farmington Rd, Suite A, Livonia, MI 48152 Phone: 248-476-6209 Fax: 248-476-6237 | |
Digestive Disease Clinic Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 18320 Farmington Rd, Livonia, MI 48152 Phone: 248-476-6100 Fax: 248-471-6452 | |
Jp Advanced Service, Corp. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 31705 Plymouth Rd, Livonia, MI 48150 Phone: 734-266-7840 Fax: 734-266-7841 |